PerkinElmer to buy diagnostics firm Oxford Immunotec Global for $591m
The acquisition is expected to enable PerkinElmer to expand its portfolio of advanced infectious disease testing solutions
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jan 21
The acquisition is expected to enable PerkinElmer to expand its portfolio of advanced infectious disease testing solutions
08 Jan 21
Commercialised as Hyalistil SYNFO in Italy and Lubristil SYNFO in Romania, SYNFO is planned to be rolled out…
08 Jan 21
The company has developed the Altius system to treat chronic post-amputation pain
08 Jan 21
QT's medical imaging technology generates 3D images with remarkable accuracy and precision, and the volumetric images are produced…
08 Jan 21
CognitOss is being developed for the treatment of chronic osteomyelitis, a progressive, inflammatory infection of the bone
08 Jan 21
ShortCut is the latest addition to Pi-Cardia’s product offering, which includes the Leaflex device – a standalone, non-implant-based…
08 Jan 21
Provides LTACs and SNFs access to cost effective, comprehensive ventilation solutions, designed to improve patient care and staff…
08 Jan 21
Novel GHz-class NMR technology enables advanced research to obtain structural, functional and binding information of intrinsically disordered proteins…
08 Jan 21
Ehave a digital therapeutics and developer of KetaDASH, a home delivery platform for patients prescribed with Ketamine infusions
08 Jan 21
Saliva-based tests rapidly expand access and testing options to combat COVID-19 in the UK